Evidence map›Paper›PMID 40395286›Full record

ArticlePhysics of fluids (Woodbury, N.Y. : 1994)2025

Hemodynamic simulation and

Dongjune A Kim, Andres Armenta, Joshua C Vaughan, Mark Terasaki, Jonathan Himmelfarb, Ying Zheng

Abstract read
In one paragraph

Article in Physics of fluids (Woodbury, N.Y. : 1994), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. High-throughput, organ-scale 3D tubule tracking using TubuleMAP.bioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dongjune A KimDepartment of Bioengineering, University of Washington, Seattle, Washington 98195, USA.
Andres ArmentaDepartment of Bioengineering, University of Washington, Seattle, Washington 98195, USA.ORCID https://orcid.org/0009-0006-5819-5260
Joshua C Vaughan
Mark TerasakiDepartment of Cell Biology, University of Connecticut, Connecticut 06030, USA.
Jonathan HimmelfarbDepartment of Medicine, Icahn School of Medicine at Mount Sinai, New York 10029, USA.

Funding

Translational center for kidney microphysiological systems to improve drug safety and efficacyU2CTR004867 · NCATS · UNIVERSITY OF WASHINGTON · PI Benjamin Solomon Freedman, Jonathan Himmelfarb · 2024 to 2026
$4.8M
A Microphysiological System for Kidney Disease Modeling and Drug Efficacy TestingUG3TR002158 · NCATS · UNIVERSITY OF WASHINGTON · PI HIMMELFARB, JONATHAN · 2017 to 2018
$2.9M
Safety and Efficacy of Human Clinical Trials Using Kidney-on-a-Chip Microphysiological SystemsUH3TR003288 · NCATS · UNIVERSITY OF WASHINGTON · PI FREEDMAN, BENJAMIN SOLOMON, HIMMELFARB, JONATHAN · 2022 to 2024
$2.3M
Safety and Efficacy of Human Clinical Trials Using Kidney-on-a-Chip Microphysiological SystemsUG3TR003288 · NCATS · UNIVERSITY OF WASHINGTON · PI HIMMELFARB, JONATHAN, KRETZLER, MATTHIAS · 2020 to 2021
$1.7M
NCATS NIH HHS U2C TR004867NCATS NIH HHS UG3 TR002158NCATS NIH HHS UG3 TR003288NCATS NIH HHS UH3 TR003288
6 · The paper itself

Abstract

The glomerulus is a critical filtration unit in the kidney, yet its complex three-dimensional architecture has long hindered a comprehensive understanding of its function and regulation. Here, we present an integrated framework that combines

Identifiers

PMID40395286
PMCPMC12087283

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.